Stony Brook University

stonybrook.edu

Total trials

190

Active

29

Phase 3

10

Total enrollment

29,634

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 15 of 15 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Minocycline2
Intravenous Famotidine1
Oral Maalox/ Mylanta1
PET Scan with [11C]ABP6881
Ropivacaine1
Celecoxib1
Nicotine transdermal patch1
PET Scan with [18F] VAT1
Sublingual Misoprostol1
IV Oxytocin1
Hydrogen3
Bupropion1
Atezolizumab + FSRT radiation1
Misoprostol1
Opioids1

Next readouts

  • 2024-06-01
  • 2026-09-05
  • 2027-01-01
  • 2027-03
  • 2027-03
  • 2027-04-01
  • 2027-08
  • 2027-12-31
  • 2029-09-30
  • 2030-03-31

Top conditions

  • Depression8
  • Anxiety7
  • Chronic Fatigue Syndrome6
  • Multiple Sclerosis5
  • Healthy4
  • Pain4
  • Breast Cancer4
  • Insulin Resistance3

Frequently asked questions about Stony Brook University

How many clinical trials does Stony Brook University have on ClinicalTrials.gov?
Stony Brook University is listed as the lead sponsor on 190 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
How many of Stony Brook University's trials are in Phase 3?
10 of Stony Brook University's trials are in Phase 3, spread across 15 active drug programs.
What therapeutic areas does Stony Brook University focus on?
Stony Brook University's most-studied conditions on ClinicalTrials.gov are Depression, Anxiety, Chronic Fatigue Syndrome, Multiple Sclerosis, Healthy.
When are Stony Brook University's next clinical trial readouts?
Stony Brook University has 10 upcoming primary-completion readouts tracked here; the soonest is “Erector Spinae Plane (ESP) Block for Renal Colic”, expected around 2024-06-01.